Literature DB >> 8835344

Polymerase chain reaction in the investigation of "relapse" following herpes simplex encephalitis.

C Dennett1, P E Klapper, G M Cleator.   

Abstract

Five cases of apparent relapse of herpes encephalitis were investigated. All patients recovered after antiviral and corticosteroid therapy. Samples of CSF taken from the patients at intervals through the initial and subsequent encephalitic episode were examined. PCR amplification of a 351 bp sequence from the Herpesvirus simplex (HSV) thymidine kinase gene demonstrated the presence of HSV DNA in CSF taken during the initial encephalitic illness but not during the second encephalitic episode. Intrathecal synthesis of HSV antibody (HSV antibody index > 1.9) was observed in all cases following the first episode, and there appeared to be no significant increase in intrathecal antibody synthesis in the second episode. High levels of CSF myelin basic protein were found during the acute phases of both the initial and the subsequent encephalitic illnesses. These data suggest that at least in our series of five patients, relapse following HSE may not be due to active viral replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835344     DOI: 10.1002/(SICI)1096-9071(199602)48:2<129::AID-JMV2>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 2.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  Unusual course of herpes simplex virus encephalitis after acyclovir therapy.

Authors:  W Preiser; B Weber; G Klös; P A Fischer; H W Doerr
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

4.  HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature.

Authors:  Nicholas A Morris; Tamara B Kaplan; Jenny Linnoila; Tracey Cho
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

5.  Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

Authors:  Avindra Nath; Joseph R Berger
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.598

6.  Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis.

Authors:  Cristina P Marques; Maxim C-J Cheeran; Joseph M Palmquist; Shuxian Hu; Stina L Urban; James R Lokensgard
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

7.  Antiviral Drugs Against Herpesviruses.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-Daspartate receptor antibodies are part of the problem.

Authors:  Romana Höftberger; Thaís Armangue; Frank Leypoldt; Francesc Graus; Josep Dalmau
Journal:  Clin Neuropathol       Date:  2013 Jul-Aug       Impact factor: 1.368

9.  Herpes simplex virus-1 encephalitis induced by chemoradiotherapy and steroids in an esophageal cancer patient: a case report.

Authors:  Masaaki Saito; Hirokazu Kiyozaki; Tamotu Obitsu; Hirofumi Imoto; Yusuke Taniyama; Osamu Takata; Toshiki Rikiyama
Journal:  BMC Cancer       Date:  2016-03-17       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.